Graid Technology Inc.
3.6.2024 20:44:43 CEST | ACCESS Newswire | Press release
Graid Technology extends its award-winning SupremeRAID™ software in a "bring your own GPU" deployment model.
SANTA CLARA, CA / ACCESSWIRE / June 3, 2024 / Graid Technology, an industry trailblazer in GPU-based RAID for NVMe and creators of groundbreaking SupremeRAID™, today announced the closed beta testing program for a new product line - SupremeRAID™ SE. With a focus on high-end workstations and consumers, SupremeRAID™ SE allows for enterprise-grade RAID data protection at the desktop level.
SupremeRAID™ SE enables professionals to harness their existing GPU hardware to configure high-performance and highly resilient RAID setups easily. The solution supports between 4 and 8 NVMe drives, making it ideal for users who require robust data management without the complexity of traditional RAID configurations.
"We proudly present the SupremeRAID™ SE beta program, now open to the public. SupremeRAID™ SE is remarkable for its ability to let users leverage their existing GPU to develop a customized RAID environment that delivers the complete performance potential of NVMe SSDs," said Leander Yu, CEO of Graid Technology. "Furthermore," Yu added, "SupremeRAID™ SE optimizes CPU resources for all applications on users' workstations or desktops, enhancing its overall value."
SupremeRAID™ SE is engineered for applications where speed and data integrity are critical:
- AI and Machine Learning: Speed up model training and experiments with fast data throughput and minimal latency.
- Multimedia Production: Enhance editing and production capabilities with accelerated data processing.
- Engineering and Design: Access and manage large engineering files efficiently and reliably.
- Scientific Computing: Handle large datasets with ease, whether for computational biology, physics simulations, or other research-intensive tasks.
SupremeRAID™ SE supports both Windows and Linux platforms, as well as several GPU models. For more information or to enroll in the beta program, visit https://beta.graidtech.com. General product availability is planned for July 2024.
______________________________
About Graid Technology and SupremeRAID™ / Graid Technology, led by a dedicated team of experts with decades of experience in the SDS, ASIC, and storage industries, continues to push boundaries in data storage innovation. SupremeRAID™, hailed as the world's only NVMe and NVMeoF RAID card to unlock the full potential of PCIe 3, 4, and 5 SSD performance, eliminates traditional RAID bottlenecks, leveraging GPU acceleration to maximize enterprise SSD performance. The company's headquarters in Silicon Valley, supported by an R&D center in Taiwan, symbolizes our global commitment to pioneering advancements in storage solutions. Visit our website or connect with us on LinkedIn.
Contact Information
Andrea Eaken
Director of Marketing, Americas & EMEA | Graid Technology
andrea.eaken@graidtech.com
949-742-9928
SOURCE: Graid Technology Inc.
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio9.2.2026 23:00:00 CET | Press release
All amounts in US dollars unless otherwise stated. VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / RE Royalties Ltd. (TSX.V:RE)(OTCQX:RROYF)(FSE:Y2V) ("RE Royalties" or the "Company") is pleased to announce a further USD $800,000 investment toward the purchase of royalties on two portfolios of distributed generation ("DG") solar projects located throughout the United States being developed by Solaris Energy Inc. ("Solaris"). The Royalty Purchase for Portfolio 1 totals USD $4.8 million, of which USD $3 million was funded at closing, as announced on January 7, 2026. The Company expects to fund the remaining USD $1 million by Q2 2026, subject to the satisfaction of applicable conditions. The Royalty Purchase for Portfolio 2 is subject to the completion of due diligence to the satisfaction of the Company, other customary closing conditions, and is expected to occur later in the year, bringing the total portfolio level royalty investment to USD $9 million. The Royalty Rate will be adju
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Innodata to Report Fourth Quarter and Fiscal Year 2025 Results5.2.2026 14:30:00 CET | Press release
NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 549 8228 North America (+44) 800 279 7040 United Kingdom (+1) 289 819 1520 International Participant Access Code 27117 # Replay dial-In (+1) 888 660 6264 North America (+1) 289 819 1325 International: Replay Passcode 27117 # Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be av
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom